Serum carotenoids, vitamin a and vitamin e in hiv infected patients

Journal of Nutritional Immunology

Volumn 4, Issue 3, 1996, Pages 25-37

  Coodley, Gregg O ^a   Coodley, Marcia K ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; BETA CAROTENE; CAROTENOID; CRYPTOXANTHIN; GAMMA TOCOPHEROL; LYCOPENE; RETINOL; XANTHOPHYLL;

ALPHA TOCOPHEROL DEFICIENCY; ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; VITAMIN BLOOD LEVEL; VITAMIN DEFICIENCY;

EID: 0029852526     PISSN: 10495150     EISSN: None     Source Type: Journal    
DOI: 10.1300/J053v04n03_03     Document Type: Article

References (82)

1. Seifter E, Rettura G, Levensen SM. Carotenoids and cell-medicated immune responses. In: Charatamboss G, Inglett G, eds. Quality of foods and beverages: recent developments in chemistry and technology. New York: Academic Press, 1984; 4:335-47.
2. Gey HF, Brobacker GB, Stahelin HB. Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer. Am J Clin Nutr 1987; 45:1368-77.
3. Graham S, Hellmann R, Marshall J, et al. Nutritional epidemiology of post-menopausal breast cancer in western New York. Am J of Epidemiology. 1991; 134:6:552-66.
4. Menkes MS, Comstock GW, Vuilleumier JP et al. Serum beta carotene, vitamins A and E, selenium and the risk of lung cancer. NEJM 1986; 315:1250-4.
5. Smith AH, Waller KD. Serum beta-carotene in persons with cancer and their immediate families. Am Jour of Epidemiol 1991; 133:7:661-71.
6. Potischman N, McCulloch CE, Byers T, et al. Breast cancer and dietary and plasma concentrations of carotenoids and vitamin A. Am J Gin Nutr 1990; 52:909-15.
7. Scrimshaw NS, Taylor CE, Gordon JE. Interaction of Nutrition and Infection. World Health Organization Monograph Series #57, 1968, p. 87-94.
8. Coodley G, Nelson H, Loveless M, Folk C. B-Carotene in HIV Infection. JAIDS. 1992; 6:272-276.
9. Dennert G, Lotan R. Effects of retinoic acid on the immune system; stimulation of T killer cell induction. Eur J Immunol 1978; 8:23-9.
10. Moriguchi S, Werner L, Watson RR. High dietary vitamin A (retinyl palmi-tate) and cellular immune function in mice. Immunology 1985; 56:169-77.
11. Watson RR, Jackson JC, Alberts DS, Hicks MJ. Cellular immune functions of adults treated with a daily, long-term low dose of 13-cis-retinoic acid. J Leukocyte Biol 1986; 39:567-77.
12. Moriguchi S, Jackson JC, Watson RR. Effects of retinoids on human lymphocyte function in vitro. Hum Toxicol 1985; 4:365-78.
13. Sklar D, Yosefov T, Friedman A. The effects of vitamin A, B-carotene and canthaxanthin on vitamin A metabolism and immune responses in the chick. Int J. Vitamin Nutr Res 1989; 59:245-50.
14. Bendich A, Shapiro S. Effect of beta carotene and canthaxanthin on immune responses of the rat. J Nutr 1986; 1 16:2254-62.
15. Prince MR. Beta carotene to prevent skin cancer. NEJM 1991; 324:924-5.
16. Coodley G, Girard DE. Vitamins and minerals in HIV infection. JGIM 1991; 6:472-79.
17. Beach RS, Mantero-Atienza E, Shor-Posner G, et al. Specific nutrient abnormalities in asymptomatic HIV-1 infection. AIDS 1992;6(7):701-8.
18. Bogden JD, Baker H, Frank O, et al. Micronutrient status and human immunodeficiency virus infection. Ann NY Acad Sci 1990;587:189-95.
19. Coodley GO, Coodley MK, Nelson HD, Loveless MO. Micronutrient concentrations in the HIV wasting syndrome. AIDS 1993; 7:1595-1600.
20. Malcolm JA, Tynn PF, Sutherland DC, Dobson P, Kelson W, Carlton J. Trace Metal and Vitamin Deficiencies in AIDS. 6th Int Conf AIDS. San Francisco. 1990; Abstract Th. B. 206.
21. Stacewicz-Sapuntzakis M, Bowen PE, Kirkendall JW, Burgess M. Simultaneous determination of serum retinol and various carotenoids: Their distribution in middle-aged men and women. J Micronutr Anal 1987; 5:27-45
22. Somner A. Vitamin A status, resistance to infection and childhood mortality. Ann NY Acad Sci 1990; 587:17-23.
23. Semba RD, Mulital Wick BT et al. Abnormal T-cell subset proportions in vitamin A deficient children. Lancet 1993; 341:5-8.
24. Watson RR. Immunological enhancement by fat-soluble vitamins, minerals, and trace metals: A factor in cancer prevention. Cancer Det and Preven 1986; 9:67-77.
25. Gensler HL, Watson RR, Moriguchi S, Bowden GT. Effects of Dietary Re-tinyl Palmitate or 13-cis-Retinoic Acid on the promotion of tumors in mouse skin. Cancer Research 1987;47:967-970.
26. Schmidt K. Antioxidant vitamins and B-carotene: effects on immunocom-petence. Am J Clin Nutr 1991;53:3835-55.
27. Diplock AT. Antioxidant nutrients and disease prevention: an overview. Am J Clin Nutr 1991;53:1895-1935.
28. Penn ND, Purkins L, Kelleher J, Heatley RV, Mascie-Taylor BH, Belfield PW. The effect of dietary supplementation with vitamins A, C, and E on cell-mediated immune function in elderly long-stay patients: A randomized controlled trial. Age and Ageing 1991; 20:169-174.
29. Coutsoudis A, Kiepiela P, Coovadia HM, Broughton M. Vitamin A supplementation enhances specific IgG antibody levels and total lymphocyte numbers while improving morbidity in measles. Pedtr Infect Dis J 1992; 11:203-9.
30. Campos FACS, Flores H, Underwood BA. Effect of infection on vitamin A status of children as measured by the relative dose response. Am J Clin Nutr 1987; 46:91-94.
31. Tengerdy RP. The role of vitamin E in immune response and disease resistance. Ann NY Acad Sci 1990; 587:24-33.
32. Lack P, Livrozet JM, Bourgeay-Causse M, Fayol V, Saint-Marc T, Touraine JL. Vitamin status at the first blood test analysis in 120 HIV seropositive patients. 9th Int Conf AIDS. Berlin, 1993; POB36-2357.
33. Beach R, Mantero-Atienza E, Van RieI F, Morgan R, Fordyce-Baum MW. Nutritional abnormalities in early HIV-1 infection-plasma vitamin levels. 5th Int Conf AIDS. Montreal, 1989; Abstract Th. S.O. 40.
34. Karter D, Karter AJ, Yarrish R, et al. Vitamin A Deficiency in Patients with AIDS: A Gross Sectional Study. 8th Int Conf AIDS. Amsterdam, 1992; Abstract POB 3698.
35. Semba RD, Graham MNH, Caiaffa WT, Margolick JB, Clement L, Vlahov D. Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection. Arch Intern Med 1993; 153:2149-2154.
36. Javier JJ, Fordyce-Baum MK, Beach RS, Gavancho M, Cabrejos G, Man-tero-Atienza. Antioxidant micronutrients and immune function in HIV-1 infection. FASEB 1990;4(4):A940 (Abstract).
37. Watson, RR, Yahya MD, Darban HR, Prabhala RH. Enhanced survival by vitamin A supplementation during a retrovirus infection causing murine AIDS. Life Sciences 1988; Vol 43, No 6,13-18.
38. Nakashima H., Harada S, Yamamota N. Effect of retinoic acid on the replication of human immunodeficiency virus in HTLV-1-positive MT-4 cells. Med Microbiol Immunol 1987; 176:189-198.
39. Turpin JA, Vargo M, Mellzer MJ. Enhanced HIV-1 replication in retinoid treated monocytes; retinoid effects mediated through mechanisms related to cell differentiation and to a direct transcriptional action on viral gene expression. J Immunol 1992; 148:2539-2546.
40. Poli G, Kinter AL, Justemenr JS, Bresslo P, Kiehri JH, Favo AS. Retinoic acid mimics transforming growth peaks B in the regulation of human immunodeficiency virus expression in monocytic cells. Proc Net Acad Sci USA 1992; 89:2689-2693.
41. Rohan TE, McMichael AJ, Baghurst PA. A Population-Based Case-Control Study of Diet and Breast Cancer in Australia. American Journal of Epidemiology 1988; 128:3:478-489.
42. Abril RE, Rybski JA, Scuderi R, Watson RR. Beta-carotene stimulates human menocyte secretion of a novel tumoroidal cytokine. J Leukocyte Biol 1989; 95:255-61.
43. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. NEJM 1993; 328:20:1444-50.
44. Riemersma RA, Wood DA, Macintyre CCA, Elton RA, Gey KF, Oliver MF. Risk of angina pectoris and plasma concentrations of vitamins A, C and E and carotene. Lancet 1991; 337:8732; 1-5.
45. Blot WJ, Li JY, Taylor PR, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. Journal of the National Cancer Institute, 1993; 85,18:1483-1491.
46. Meydani SN, Barklund MP, Liu S et al. Vitamin E supplementation enhances cell mediated immunity in healthy elderly subjects. Am J Gin Nutr 1990; 52:557-63.
47. Miguez-Burbano MJ, Mantero-Atienza E, Fletcher MA, Baum MK. Elevated IgE in relationship to plasma vitamin E levels in early HIV-1 disease. 9th Int Conf AIDS. Berlin, 1993; P0-A23-0511.
48. Hollins TD. T4 cell receptor distortion in acquired immune deficiency syndrome. Medical Hypotheses 1988;26: 107-11.
49. Kline K, Rao A, Romach E, Kidao S, Morgan TJ, Sanders BG. Vitamin E effects on retrovirus-induced immune dysfunctions. Ann NY Acad Sci 1990; 587:294-6.
50. Odeleye OE, Watson RR. The potential role of vitamin E in the treatment of immunologic abnormalities during acquired immune deficiency syndrome. Prog Food Nutr Sci 1991;15(1-2):1-19.
51. Gogu SR, Beckman BS, Rangan SRS, Agraral KC. Increased therapeutic efficacy of Zidovudine in combination with vitamin E. Biochemical and Biophysical Research Communications 1989;165(1):401-7.
52. Bendich A, Olson JA. Biological actions of carotenoids. FASEB 1989;3:1927-32.
53. Bendich, A. Biological Functions of Dietary Carotenoids. Annals New York Academy of Sciences, 1993; 61-67.
54. Nierenberg DW, Stukel TA, Baron JA, Dain BJ, Greenberg ER, & The Skin Cancer Prevention Study Group. Determinants of plasma levels of beta-carotene and retinol. Am J of Epidemiology 1989; 130:3:511-20.
55. Erdman JW Jr, Bierer T, Gugger ET. Absorption and transport of carote-noids. NY Acad Sci Feb 6-9, 1993:9 (abstract 9).
56. Bendich A. The safety of beta-carotene. Nutr Cancer 1988; 11:207-214.
57. Dimitrov NV, Meyer C, Ullrey DE, et al. Bioavailability of B-carotene in humans. Am J Clin Nutr 1988; 48:298-304.
58. Bendich A. B-Carotene and the immune response. Proc Nutri Soc 1991;50(2):263-74.
59. Alexander M, Newmark H, Miller RG. Oral beta-carotene can increase the number of OKT4+ cells in human blood. Immunology Letters 1985; 9:221-224.
60. Poppel GV, Spanhakk S, Ockhuizen T. Effect of B-carotene on immunological indexes in healthy male smokers. Am J Clin Nutr 1993; 57:402-7.
61. Watson RR, Prabhala RH, Plezia PM, Alberts DS. Effect of B-carotene on lymphocyte sub-populations in elderly humans: evidence for a dose-response relationship. Am J Clin Nutr 1991; 53; 904.
62. Prabhala RH, Garewal HS, Hick MJ, Sampliner RE, Watson RR. The effects of 13-cis-Retinoic acid and beta-carotene on cellular immunity in humans. Cancer 1991; 67:1556-60.
63. Brock HE, Berry G, Moch PA, et al. Nutrients in diet and plasma and risk of in situ cervical cancer. JNCI 1988; 80:580-5.
64. Prabhala RH, Garewal HS, Hick MJ, Sampliner RE, Watson RR. The effects of 13-cis-Retinoic acid and beta-carotene on cellular immunity in humans. Cancer 1991; 67:1556-60.
65. Brock HE, Berry G, Moch PA, et al. Nutrients in diet and plasma and risk of in situ cervical cancer. JNCI 1988; 80:580-5.
66. Gaziano JM, Manosn JE, Branch LG, et al. A prospective study of B-caro-tene in fruits and vegetables and decreased cardiovascular mortality in the elderly. Am J Epidemiology. 1992; 136: 985: abstract.
67. Jinno K, Okada Y, Tanimizu M, et al. Decreased serum levels of beta-carotene in patients with hepatocellular carcinoma. International Hepatol. Commun 1994; 2:43-46.
68. Hennekens GH. Beta Carotene and risk of cardiovascular disease. NY Acad Sc Feb 7-9, 1993:abstract 17.
69. Hunter DT, Manson JE, Golditz GA et al. A prospective study of the intake of vitamins C, E and A and the risk of breast cancer. NEJM 1993; 329:4:234-40.
70. Greenberg ER, Baron JA, Stukel TA, et al. A clinical trial of beta-carotene to prevent basal-cell and squamous-cell cancer of the skin. NEJM 1990; 323:12:789-794.
71. Greenberg ER, Baron JA, Tosteson TD. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. NEJM 1994; 331:141-7.
72. Garewel HS, Meyskens FL, Killen D et al. Response of oral leukoplakia to beta carotene. J Clin Oncol 1990; 8:1715-1720.
73. Coodley G. Beta carotene therapy in human immunodeficiency virus infection. Clinical Research 1991;39(2):634 (Abstract).
74. Garewal HS, Ampel NM, Watson RR, Prabhala RH, Dols CL. A preliminary trial of beta carotene in subjects infected with the Human Immunodeficiency virus. Journal of Nutrition 1992;122:35:728-32.
75. Fryburg DA, Mark R, Askenase PW, Patterson TF. The immunostimulato-ry effects and safety of beta carotene in patients with AIDS. 8th Int Conf AIDS. Amsterdam. 1992; Abstract POB 3458.
76. Bianchi-Santamaria A, Fedeli S, Santamaria L. Possible activity of beta-carotene in patients with the AIDS related complex. Med Oncol and Tumor Phar-macother 1992; 9:3:151-153.
77. Tricoire J, Periquet B, Jammes N, Ane M, Robert A, Thouvenotf JP. Effect of B-carotene in immune and nutritional status in HIV infected children. Ind & Ag PRDTS 1993; 14:42.
78. Loya S, Kashman Y, Hizi A. The carotenoid halocynthiaxanthin: A novel inhibitor of the reverse transcryptases of human immunodelivery viruses type 1 and type 2. Arch Biochem Biophys 1992; 293:208-212.
79. Morrey JD, Bourn JM, Bunch TD, Sidell RW, Rosen CA. HIV-1 LTR-ac-tivation model: evaluation of various agents in skin of transgenic mice. JAIDS 1992; 5:1-9.
80. Hersey P, Haren G, Hasic E, Edwards A. Alteration of T cell subsets and induction of suppressor T cell activity in normal subjects with exposure in sunlight. J Immunol 1983; 31:171-174.
81. Fuller CJ, Faulkner H, Bendich A, Parker RS, Roe D. Effect of beta carotene supplementation on photosuppression of delayed type hypersensitivity in normal young men. Am J Clin Nutr 1992; 56:684-690.
82. Greenblatt RM, Hollander H, McMaster JR, Henke CJ. Polypharmacy among patients attending an AIDS clinic: utilization of prescribed, unorthodox, and investigational treatments. JAIDS 1991; 4136-143.